D W Davis

Author PubWeight™ 43.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. Cancer Res 2001 1.80
2 Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease. Ann Oncol 2011 1.70
3 Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 2000 1.58
4 Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clin Cancer Res 2000 1.47
5 Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res 1999 1.43
6 Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer 2008 1.43
7 Field efficacy of sweet corn hybrids expressing a Bacillus thuringiensis toxin for management of Ostrinia nubilalis (Lepidoptera: Crambidae) and Helicoverpa zea (Lepidoptera: Noctuidae). J Econ Entomol 2001 1.40
8 Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis. Cancer Res 2000 1.36
9 Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin. Am J Pathol 2000 1.22
10 Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma. Clin Cancer Res 2000 1.17
11 Regional ketone body utilization by rat brain in starvation and diabetes. Am J Physiol 1986 1.15
12 Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants. J Natl Cancer Inst 1975 1.12
13 Cerebral glucose use measured with [14C]glucose labeled in the 1, 2, or 6 position. Am J Physiol 1985 1.07
14 Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel. Clin Cancer Res 2000 1.03
15 Comparison of the effects of volatile anesthetics on brain glucose metabolism in rats. Anesthesiology 1987 1.01
16 Apoptosis in mycobacterium tuberculosis infection in mice exhibiting varied immunopathology. J Pathol 2000 0.98
17 Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment. Oncogene 2000 0.98
18 Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages. Cancer Res 2000 0.91
19 Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha. Neoplasia 2001 0.90
20 Three-dimensional representation and analysis of brain energy metabolism. Science 1987 0.89
21 p53 and Fas ligand are required for psoralen and UVA-induced apoptosis in mouse epidermal cells. Cell Death Differ 2002 0.87
22 Failure of glucose and branched-chain amino acids to normalize brain glucose use in portacaval shunted rats. J Neurochem 1986 0.87
23 Regional cerebral glucose utilization in rats with portacaval anastomosis. J Neurochem 1983 0.87
24 Early establishment of cerebral dysfunction after portacaval shunting. Am J Physiol 1990 0.85
25 Age related changes in auto-erythrocyte rosettes in the C57BL/6J and NZB/BINJ mice. Mech Ageing Dev 1979 0.85
26 Portacaval anastomosis: brain and plasma metabolite abnormalities and the effect of nutritional therapy. J Neurochem 1984 0.84
27 Brain energy metabolism in streptozotocin-diabetes. Biochem J 1988 0.84
28 A methodological approach to the prediction of anticancer drug effect in humans. Cancer Res 1979 0.83
29 Comparison of the effects of volatile anesthetics in varying concentrations on brain energy metabolism with brain ischemia in rats. Neurochem Res 1992 0.83
30 Nutritional strategies and growth in extremely low birth weight infants with bronchopulmonary dysplasia over the past 10 years. J Perinatol 2011 0.82
31 Factors related to research utilization by registered nurses in Kentucky. Ky Nurse 2000 0.81
32 Dental malocclusion in native children of British Columbia, Canada. Community Dent Oral Epidemiol 1996 0.81
33 Regional cerebral glucose utilization during Althesin anesthesia. Anesthesiology 1984 0.81
34 Endothelial cell apoptosis is inhibited by a soluble factor secreted by human colon cancer cells. Int J Cancer 2001 0.81
35 Glucose availability to individual cerebral structures is correlated to glucose metabolism. J Neurochem 1983 0.80
36 Regional brain glucose use in unstressed rats after two days of starvation. Metab Brain Dis 1987 0.80
37 Regional amino acid transport into brain during diabetes: effect of plasma amino acids. Am J Physiol 1987 0.79
38 Caries experience of Native children of British Columbia, Canada, 1980-1988. Community Dent Oral Epidemiol 1993 0.79
39 Comparison of [14C]glucose and [14C]deoxyglucose as tracers of brain glucose use. Am J Physiol 1988 0.79
40 Polyclonal systemic immunoblast proliferation: an unusual hematologic entity presenting as a medical examiner case. J Forensic Sci 2001 0.79
41 The influence of nitrous oxide on methionine, S-adenosylmethionine, and other amino acids. Anesthesiology 1986 0.78
42 Regional cerebral glucose utilization measured with [14C]glucose in brief experiments. Am J Physiol 1983 0.77
43 Gamete formation via meiotic nuclear restitution generates fertile amphiploid F1 (oat×maize) plants. Sex Plant Reprod 2012 0.76
44 Regional blood-brain barrier transport of glucose after portacaval anastomosis. Metab Brain Dis 1986 0.76
45 Regional brain glucose utilization in rats during etomidate anesthesia. Anesthesiology 1986 0.75
46 Aerobic glycolysis by the pituitary gland in vivo. J Neurochem 1984 0.75
47 Tumor immunology of experimental osteosarcoma. Clin Orthop Relat Res 1978 0.75
48 HOW THE COLLEGE CAN AID THE OYSTER INDUSTRIES. Science 1930 0.75
49 Congenital duodenal obstruction. Neonatal Netw 1985 0.75
50 Sequential appearance of auto-erythrocyte antibody immunoglobulin classes with age. J Gerontol 1979 0.75
51 Alternative systems--Massachusetts and New Jersey. Curr Concepts Hosp Pharm Manage 1984 0.75
52 Cerebral glucose utilization in awake unstressed rats. Am J Physiol 1983 0.75
53 Origins of manganese in air particulates in California. JAPCA 1988 0.75
54 Change in the nursing workforce: our views and suggestions for dealing with it. Ky Nurse 1998 0.75
55 Hypoaspis nr. aculeifer: a Mite Predacious on Root-knot and Cyst Nematodes. J Nematol 1983 0.75
56 Regional transport of some essential nutrients across the blood-brain barrier in normal and diseased states. Ann N Y Acad Sci 1988 0.75
57 Hospital-affiliated headache clinics in the managed care era. Headache 1996 0.75
58 Maintenance of MOPC 104E myeloma in plateau phase. Cancer Res 1980 0.75
59 Guiding mothers of high-risk infants in obtaining social support. MCN Am J Matern Child Nurs 1998 0.75
60 Lung mechanics and oxygen consumption during spontaneous ventilation and severe heart failure. Chest 1992 0.75
61 Congenital Absence of the Cervix Uteri Complicating Pregnancy. Can Med Assoc J 1936 0.75
62 Dentistry in Africa. Mcgill Dent Rev 1968 0.75